Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion type Assertion NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_head.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion description "[Phase II randomized trial comparing high-dose IFN-?2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion evidence source_evidence_literature NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion SIO_000772 23833309 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion wasDerivedFrom befree-2016 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.
- NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_assertion wasGeneratedBy ECO_0000203 NP1092095.RAhJ03Ox19XxavUqwUQ0hn54oYU6lmtcugmxm4HOJwxdU130_provenance.